Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
5.07
+0.25 (5.19%)
At close: Oct 8, 2025, 4:00 PM EDT
5.20
+0.13 (2.56%)
After-hours: Oct 8, 2025, 7:57 PM EDT
Protara Therapeutics Market Cap
Protara Therapeutics has a market cap or net worth of $195.61 million as of October 8, 2025. Its market cap has increased by 379.44% in one year.
Market Cap
195.61M
Enterprise Value
53.95M
1-Year Change
379.44%
Ranking
Category
Stock Price
$5.07
Market Cap Chart
Since October 22, 2014, Protara Therapeutics's market cap has increased from $140.90M to $195.61M, an increase of 38.83%. That is a compound annual growth rate of 3.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 186.00M | 70.80% |
| Dec 31, 2024 | 108.90M | 411.27% |
| Dec 29, 2023 | 21.30M | -29.47% |
| Dec 30, 2022 | 30.20M | -60.16% |
| Dec 31, 2021 | 75.80M | -72.07% |
| Dec 31, 2020 | 271.40M | 3,292.50% |
| Dec 31, 2019 | 8.00M | -81.65% |
| Dec 31, 2018 | 43.60M | 30.15% |
| Dec 29, 2017 | 33.50M | 6.35% |
| Dec 30, 2016 | 31.50M | -87.68% |
| Dec 31, 2015 | 255.70M | 49.44% |
| Dec 31, 2014 | 171.10M | 21.43% |
| Oct 22, 2014 | 140.90M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 757.36B |
| Johnson & Johnson | 454.91B |
| AbbVie | 411.31B |
| UnitedHealth Group | 329.36B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.52B |